700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Case Report Open Access
Reports of coincident amyotrophic lateral sclerosis, rheumatoid arthritis, and anti- TNF treatment are scant. We report a new case of a patient with other comorbidities exposed to long-term adalimumab treatment in whom a potential neurotoxic side effect of the drug must be considered. We speculate whether continued exposure after the diagnosis of ALS could explain the severity of her outcome.
Amyothrophic lateral sclerosis, Anti-TNF therapy, Adalimumab rheumatoid arthritis, Translational Biomedical Research, Sclerosis, Medical Case Report